Palisade Bio (PALI) Profit After Tax (2010 - 2026)
Palisade Bio (PALI) reported Profit After Tax of -$9.6 million for Q1 2026, down 330.49% year-over-year from $4.2 million in Q1 2025, and down 7.88% quarter-over-quarter from -$8.9 million in Q4 2025.
Palisade Bio (PALI) Profit After Tax (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 17 years of Profit After Tax data on file, last reported at -$9.6 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$9.6 million, down 330.49% year-over-year; the trailing twelve-month figure through Mar 2026 was -$24.2 million (down 83.78% YoY), and the FY2025 annual result was -$16.8 million, down 16.23% from the prior year.
- Profit After Tax eased to -$9.6 million in Q1 2026 per PALI's latest filing, from -$8.9 million in the prior quarter.
- Over five years, Profit After Tax peaked at -$2.2 million in Q1 2025 and troughed at -$9.6 million in Q1 2026.
- A 5-year average of -$4.0 million and a median of -$3.5 million in 2024 frame the typical range for Profit After Tax.
- On a YoY basis, Profit After Tax climbed as much as 92.62% in 2022 and fell as far as 446.69% in 2022.
- A 5-year view of Profit After Tax shows it stood at -$3.7 million in 2022, then grew by 20.13% to -$3.0 million in 2023, then fell by 12.55% to -$3.3 million in 2024, then sank by 166.12% to -$8.9 million in 2025, then retreated by 7.88% to -$9.6 million in 2026.
- Business Quant data shows PALI's Profit After Tax at -$9.6 million in Q1 2026, -$8.9 million in Q4 2025, and -$2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | -9.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.60 Mn |
| Dec 31, 2025 | -8.90 Mn |
| Sep 30, 2025 | -2.87 Mn |
| Jun 30, 2025 | -2.78 Mn |
| Mar 31, 2025 | -2.23 Mn |
| Dec 31, 2024 | -3.34 Mn |
| Sep 30, 2024 | -3.49 Mn |
| Jun 30, 2024 | -4.08 Mn |
| Mar 31, 2024 | -3.53 Mn |
| Dec 31, 2023 | -2.97 Mn |
| Sep 30, 2023 | -3.60 Mn |
| Jun 30, 2023 | -3.39 Mn |
| Mar 31, 2023 | -2.34 Mn |
| Dec 31, 2022 | -3.72 Mn |
| Sep 30, 2022 | -3.99 Mn |
| Jun 30, 2022 | -2.34 Mn |
| Mar 31, 2022 | -4.21 Mn |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | 8.09 Mn |
| Jun 30, 2021 | -31.75 Mn |